VSee Health, Inc. is a technology company that specializes in providing telehealth solutions aimed at enhancing patient care through innovative communication tools. Their platform enables healthcare providers to conduct virtual consultations, facilitating remote access to medical services while improving efficiency and patient engagement. VSee's offerings include video conferencing, secure messaging, and remote patient monitoring, catering to a diverse range of healthcare settings, from hospitals to outpatient clinics. The company is dedicated to advancing healthcare delivery and making quality medical services more accessible to patients. Read More
SAN JOSE, CA, MA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024").
VSee Health (Nasdaq: VSEE ) is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSEE highly scalable, customizable telehealth building blocks each meet stringent security standards.
SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc. (Nasdaq: VSEE) (the "Company"), a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") in a letter dated September 15, 2025, that the Nasdaq Hearings Panel (the "Panel") had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly report ending March 31, 2025 and June 30, 2025 respectively (together, the "Delayed Reports") on Form 10-Q by October 15, and (ii) demonstrating compliance with the Equity Rule by December 1, 2025.
SAN JOSE, CALIFORNIA / ACCESS Newswire / September 2, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, today announced the expansion implementation of 17/of 25 teleradiology. VSee health was awarded an increase to 22 hospitals by a significant vendor who recently awarded an additional 3 hospitals. VSee Health has now implemented 17 of those hospitals by end of August this year. The contract value with this expansion is almost 3 million per year in ARR.
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
SAN JOSE, CA / ACCESS Newswire / August 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market.
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Fourth paragraph, first sentence of release dated July 14, 2025 should read: Dr. Ramon Lizardo MD, CEO of Tele911 (instead of Dr. Ramone Lizardo, MD, CEO of Tele911).
Imagine a world where stroke recovery happens from the comfort of home. A world where AI-powered nursing robots reduce hospital costs, and maternal care reaches the most remote corners of the world with just a mobile signal. That’s not a futuristic dream—it’s the reality VSee Health (Nasdaq: VSEE) is building today.
VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions.
VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq’s listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”).
VSee Health (Nasdaq: VSEE ) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSEE accelerates telehealth adoption by enabling seamless, scalable and secure digital health solutions across hospitals, governments, and enterprise organizations.
